|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eppert K, Wunder JS, Aneliunas V, Kandel R
and Andrulis IL: von Willebrand factor expression in osteosarcoma
metastasis. Mod Pathol. 18:388–397. 2005. View Article : Google Scholar
|
|
4
|
Osman A: MicroRNAs in health and disease -
basic science and clinical applications. Clin Lab. 58:393–402.
2012.
|
|
5
|
Zhao G, Cai C, Yang T, et al: MicroRNA-221
induces cell survival and cisplatin resistance through PI3K/Akt
pathway in human osteosarcoma. PLoS One. 8:e539062013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
9
|
Dieckmann KP, Spiekermann M, Balks T, et
al: MicroRNAs miR-371-3 in serum as diagnostic tools in the
management of testicular germ cell tumours. Br J Cancer.
107:1754–1760. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takahashi M, Cuatrecasas M, Balaguer F, et
al: The clinical significance of MiR-148a as a predictive biomarker
in patients with advanced colorectal cancer. PLoS One.
7:e466842012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang C, Hou C, Zhang H, et al: miR-126
functions as a tumor suppressor in osteosarcoma by targeting Sox2.
Int J Mol Sci. 15:423–437. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao H, Li M, Li L, et al: MiR-133b is
down-regulated in human osteosarcoma and inhibits osteosarcoma
cells proliferation, migration and invasion, and promotes
apoptosis. PLoS One. 8:e835712013. View Article : Google Scholar
|
|
13
|
Wang Z and Cai H, Lin L, Tang M and Cai H:
Upregulated expression of microRNA-214 is linked to tumor
progression and adverse prognosis in pediatric osteosarcoma.
Pediatr Blood Cancer. 61:206–210. 2014. View Article : Google Scholar
|
|
14
|
Tang M, Lin L, Cai H, Tang J and Zhou Z:
MicroRNA-145 downregulation associates with advanced tumor
progression and poor prognosis in patients suffering osteosarcoma.
Onco Targets Ther. 6:833–838. 2013.PubMed/NCBI
|
|
15
|
Zhou Y, Huang Z, Wu S, et al: miR-33a is
up-regulated in chemoresistant osteosarcoma and promotes
osteosarcoma cell resistance to cisplatin by down-regulating TWIST.
J Exp Clin Cancer Res. 33:122014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chandrasekar V and Dreyer JL: microRNAs
miR-124, let-7d and miR-181a regulate cocaine-induced plasticity.
Mol Cell Neurosci. 42:350–362. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li KK, Pang JC, Ching AK, et al: miR-124
is frequently down-regulated in medulloblastoma and is a negative
regulator of SLC16A1. Hum Pathol. 40:1234–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liang YJ, Wang QY, Zhou CX, et al: MiR-124
targets Slug to regulate epithelial-mesenchymal transition and
metastasis of breast cancer. Carcinogenesis. 34:713–722. 2013.
View Article : Google Scholar :
|
|
19
|
Zhang H, Wang Q, Zhao Q and Di W: MiR-124
inhibits the migration and invasion of ovarian cancer cells by
targeting SphK1. J Ovarian Res. 6:842013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wilting SM, van Boerdonk RA, Henken FE, et
al: Methylation-mediated silencing and tumour suppressive function
of hsa-miR-124 in cervical cancer. Mol Cancer. 9:1672010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia J, Wu Z, Yu C, et al: miR-124 inhibits
cell proliferation in gastric cancer through down-regulation of
SPHK1. J Pathol. 227:470–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang J, Lu Y, Yue X, et al: MiR-124
suppresses growth of human colorectal cancer by inhibiting STAT3.
PLoS One. 8:e703002013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zheng F, Liao YJ, Cai MY, et al: The
putative tumour suppressor microRNA-124 modulates hepatocellular
carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut.
61:278–289. 2012. View Article : Google Scholar
|
|
24
|
Wang P, Chen L, Zhang J, et al:
Methylation-mediated silencing of the miR-124 genes facilitates
pancreatic cancer progression and metastasis by targeting Rac1.
Oncogene. 33:514–524. 2014. View Article : Google Scholar
|
|
25
|
Shi XB, Xue L, Ma AH, et al: Tumor
suppressive miR-124 targets androgen receptor and inhibits
proliferation of prostate cancer cells. Oncogene. 32:4130–4138.
2013. View Article : Google Scholar
|
|
26
|
Enneking WF, Spanier SS and Goodman MA: A
system for the surgical staging of musculoskeletal sarcoma. Clin
Orthop Relat Res. 106–120. 1980.PubMed/NCBI
|
|
27
|
Rosen G, Caparros B, Huvos AG, et al:
Preoperative chemotherapy for osteogenic sarcoma: selection of
postoperative adjuvant chemotherapy based on the response of the
primary tumor to preoperative chemotherapy. Cancer. 49:1221–1230.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen X, Chen J, Gan S, et al: DNA damage
strength modulates a bimodal switch of p53 dynamics for cell-fate
control. BMC Biol. 11:732013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Deng X, Ma L, Wu M, et al: miR-124
radiosensitizes human glioma cells by targeting CDK4. J Neurooncol.
114:263–274. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brennecke J, Stark A, Russell RB and Cohen
SM: Principles of microRNA-target recognition. PLoS Biol.
3:e852005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Krek A, Grün D, Poy MN, et al:
Combinatorial microRNA target predictions. Nat Genet. 37:495–500.
2005. View
Article : Google Scholar : PubMed/NCBI
|
